April 17th 2025
The CDC advisory committee also endorsed GSK's pentavalent meningococcal vaccine.
April 15th 2025
Data from the EAGLE-1 study found gepotidacin to be noninferior to ceftriaxone plus azithromycin for treating uncomplicated urogenital gonorrhea.
April 9th 2025
AAAAI 2025: RSV vaccine and immunoprophylaxis uptake remained low in 2024 across infants, pregnant individuals, and older adults.
As the US measles outbreak tops 600 cases, Texas reported a second child's death in a young girl who was unvaccinated and had no underlying health conditions.
Your daily dose of the clinical news you may have missed.
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Beyond Boomers: CDC Urges HCV Screening for All US Adults
HCV is now diagnosed in millennials at about the same rate as in baby boomers; CDC responds with a recommendation for HCV screening in all adults aged ≥18 years.
COVID-19 and Influenza: How Can We Mitigate Certain Calamity?
A pulmonary and critical care specialist identifies 4 factors that will, in part, determine the severity of the 2020-2021 flu season and that can inform preparation.
Remdesivir New Drug Application Submitted to FDA
The investigational antiviral remdesivir in phase 3 clinical trials led to faster time to recovery vs placebo and was found to be safe.
COVID-19 Vaccines: Will Next-gen Platforms Be First?
There are nearly 30 COVID-19 vaccine candidates in human trials. Confused? Here's a short primer on the old and new development platforms and the pros and cons.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of August 10, 2020
US confirmed cases of COVID-19 surpassed 5 million; global recoveries have exceeded 12 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Immunization During COVID-19: CDC Vaccination Guidance for Clinicians
Communicating the importance of immunization to wary patients is key during the COVID-19 pandemic. Check out our new slideshow for the most recent CDC guidance for clinicians.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of August 5, 2020
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of August 4, 2020
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of August 3, 2020
US confirmed cases of COVID-19 number nearly 4.6 million; global cases have surpassed 18 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
NIH Updates COVID-19 Treatment Guidance on Corticosteroids, Advance Planning
The National Institutes of Health updated guidance on use of dexamethasone and substitutes in critically ill patients, and on ensuring surrogate decision makers are identified.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of July 31, 2020
US confirmed cases of COVID-19 number nearly 4.5 million; global cases have surpassed 17 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
US Vaccination Rates Ranked by State: 5 Highest, 5 Lowest in 8 Categories
Flu vaccination coverage for adults is highest in West Virginia, lowest in Louisiana. Where does your state rank on flu, HPV, pneumococcal and 5 other vaccines?
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of July 30, 2020
MJH Hosts Free Webinar on COVID-19 Vaccine Candidates
A trio of experts will discuss the prospects of a handful of COVID-19 vaccine candidates which are entering phase 3 trials.
COVID-19 Update: US and Global Cases and Recoveries as of July 28, 2020
Global confirmed cases of COVID-19 are approaching 16.5 million. We summarize more of today's global and US data from the Johns Hopkins COVID-19 interactive map.
Phase 3 Trial of Moderna/NIH COVID-19 Vaccine Candidate is Launched
COVID-19 vaccine hopeful mRNA-1273 will be administered to 30,000 trial volunteers at 89 US research sites.
COVID-19 Update: US and Global Cases and Recoveries as of July 27, 2020
Global confirmed cases of COVID-19 have surpassed 16 million. We summarize more of today's global and US data from the Johns Hopkins COVID-19 interactive map.
Study: After COVID-19, Symptoms Persist for Majority of Patients
JAMA: After recovery from COVID-19, a majority of patients reported persistence of at least 1 symptom; more than half reported ≥3 symptoms.
Survey: More than One-quarter of Parents Hesitant to Vaccinate Children Against Flu
Parental doubts about efficacy drive flu-shot hesitancy, according to a new survey, and impact routine vaccination rates, as well.
COVID-19 in the ICU: A Cardiothoracic Surgeon's Experience
Cardiothoracic surgeon Brian Lima, MD spent weeks in a large metropolitan New York City ICU treating the sickest patients with COVID-19. He shares details.
FDA Issues EUA for Combined Influenza-COVID-19 Diagnostic
The EUA is the third for diagnostics designed for detection and differentiation of the viruses that cause COVID-19 and the flu.
Scientists Appeal to WHO to Recognize COVID-19 Airborne Transmission Threat
A letter to the World Health Organization signed by more than 200 scientists from around the world strongly urges the agency to acknowledge airborne transmission of the SARS-Cov2 virus.
NIH: Dexamethasone Recommendations for Patients with COVID-19
The NIH COVID-19 Treatment Guidelines Panel published guidelines on use of the corticosteroid dexamethasone in patients severely ill with COVID-19.
Novel Study Suggests HCV-positive Livers Safe for Transplantation
Patients who received an HCV-positive liver for transplantation and were later treated performed as well in recovery as those who did not, a recent study suggests.
511 Epidemiologists Weigh In on Resuming 20 Everyday Activities
The New York Times asked 511 epidemiologists when they might resume hair cuts, shaking hands, air travel, bus rides, and 15 other "normal" activities suspended during COVID-19 social distancing.
Asymptomatic Cornovavirus Spread: What the WHO Meant
"Asymptomatic coronavirus spread is rare." World Health Organization explains the miscommunication.
UK COVID-19 Vaccine Begins Phase II/III Trials
University of Oxford researchers will recruit more than 10 000 participants and evaluate groups of young and elderly to evaluate immune response across the lifespan.
Remdesivir Bests Placebo in Time to Recovery from COVID-19
The recovery rate of patients with severe COVID-19 infection who received remdesivir was 31% faster than those in a placebo group, according to the NIH.
COVID-19 Impressions & Misconceptions in the US and UK
One-quarter of US and UK adults indicated a package from China may transmit the SARS-CoV-2 virus. Click through more perceptions, true and false, from a recent survey.
Sanofi, GSK Partner to Develop COVID-19 Vaccine
Phase I clinical trials of the adjuvanted vaccine against the SARS-CoV-2 virus could begin in the second half of 2020, according to the companies.